Neutrophil Activation in Severe Asthma and Corticosteroid Resistance
Author Information
Author(s): Bhupinder S Mann, Kian Fan Chung
Primary Institution: National Heart & Lung Institute, Imperial College & Royal Brompton Hospital
Hypothesis
The study investigates whether circulating neutrophils in severe asthma exhibit activation markers and their response to corticosteroids.
Conclusion
Blood neutrophils in severe asthma are activated and not inhibited by oral corticosteroids, suggesting their role in the disease's pathogenesis.
Supporting Evidence
- Neutrophils in severe asthma show increased expression of activation markers.
- Prednisolone did not reduce neutrophil activation in severe asthma patients.
- Increased CD35 and CD11b expression was observed in severe steroid-dependent asthma.
Takeaway
In severe asthma, the body's immune cells called neutrophils are very active and don't respond to common asthma medications, which might make the condition worse.
Methodology
The study compared blood neutrophils from different asthma severity groups and assessed the effects of prednisolone on their activation markers.
Potential Biases
Potential bias due to the chronic corticosteroid therapy in severe asthma patients affecting neutrophil function.
Limitations
The study was not blinded or placebo-controlled, which may affect the reliability of the results.
Participant Demographics
10 patients each from mild, moderate-to-severe, and severe steroid-dependent asthma groups, plus 10 healthy non-asthmatic volunteers.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website